BTIG acted as sole book running manager for the offering.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OTLK:
- Outlook Therapeutics Reports Improved Financials Amid Challenges
- Outlook Therapeutics announces common stock, warrants offering
- Outlook Therapeutics price target lowered to $8 from $10 at Guggenheim
- Biotech Alert: Searches spiking for these stocks today
- Outlook Therapeutics reports Q2 EPS (40c), consensus (55c)